Canada Life’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.08M Buy
523,383
+1,220
+0.2% +$17.1K 0.01% 612
2025
Q4
$6.51M Sell
522,163
-285,156
-35% -$3.08M 0.01% 645
2025
Q3
$7.76M Sell
807,319
-2,282
-0.3% -$22.2K 0.01% 643
2025
Q2
$7.24M Sell
809,601
-964,433
-54% -$8.15M 0.01% 643
2025
Q1
$15.5M Buy
1,774,034
+459,414
+35% +$4.82M 0.03% 466
2024
Q4
$16.4M Buy
1,314,620
+23,430
+2% +$288K 0.03% 461
2024
Q3
$15M Buy
1,291,190
+4,130
+0.3% +$47.6K 0.03% 483
2024
Q2
$13.7M Buy
1,287,060
+150,019
+13% +$1.66M 0.03% 486
2024
Q1
$13.6M Buy
1,137,041
+186,619
+20% +$2.25M 0.03% 487
2023
Q4
$10.3M Buy
950,422
+20,308
+2% +$194K 0.02% 527
2023
Q3
$9.16M Buy
930,114
+51,504
+6% +$536K 0.02% 537
2023
Q2
$8.81M Buy
878,610
+80,536
+10% +$769K 0.02% 550
2023
Q1
$7.68M Buy
798,074
+111,980
+16% +$1.24M 0.02% 596
2022
Q4
$7.66M Sell
686,094
-123,907
-15% -$1.29M 0.02% 585
2022
Q3
$6.89M Buy
810,001
+102,774
+15% +$1.01M 0.02% 588
2022
Q2
$7.41M Buy
707,227
+11,716
+2% +$128K 0.02% 595
2022
Q1
$7.97M Buy
+695,511
New +$9.16M 0.02% 643
2021
Q4
Sell
-700,819
Closed -$9.56M 2548
2021
Q3
$9.56M Buy
700,819
+11,318
+2% +$161K 0.02% 594
2021
Q2
$9.85M Sell
689,501
-320,681
-32% -$4.64M 0.02% 606
2021
Q1
$14.1M Sell
1,010,182
-965,862
-49% -$15.7M 0.03% 482
2020
Q4
$37M Buy
1,976,044
+615,257
+45% +$10M 0.07% 279
2020
Q3
$20.2M Buy
1,360,787
+248,446
+22% +$3.97M 0.04% 381
2020
Q2
$17.8M Buy
1,112,341
+815,016
+274% +$13.2M 0.04% 385
2020
Q1
$4.46M Sell
297,325
-2,743
-0.9% -$52.5K 0.01% 660
2019
Q4
$5.98M Sell
300,068
-25,836
-8% -$481K 0.01% 681
2019
Q3
$6.45M Sell
325,904
-120
-0% -$2.35K 0.02% 622
2019
Q2
$6.2M Sell
326,024
-546,503
-63% -$12.1M 0.01% 664
2019
Q1
$24.7M Sell
872,527
-18,844
-2% -$550K 0.07% 281
2018
Q4
$24M Buy
891,371
+247,098
+38% +$8.01M 0.07% 273
2018
Q3
$23.6M Sell
644,273
-272,993
-30% -$10.2M 0.06% 315
2018
Q2
$33.2M Buy
917,266
+316,914
+53% +$12.4M 0.08% 256
2018
Q1
$24.7M Sell
600,352
-4,213
-0.7% -$180K 0.06% 303
2017
Q4
$25.5M Buy
604,565
+4,895
+0.8% +$187K 0.06% 303
2017
Q3
$18.6M Buy
599,670
+41,595
+7% +$1.41M 0.05% 360
2017
Q2
$21.6M Buy
558,075
+33,729
+6% +$1.29M 0.06% 320
2017
Q1
$20.5M Buy
524,346
+190,710
+57% +$7.69M 0.06% 330
2016
Q4
$12.8M Buy
333,636
+7,590
+2% +$282K 0.04% 427
2016
Q3
$12.4M Buy
326,046
+21,521
+7% +$957K 0.04% 431
2016
Q2
$13.1M Buy
304,525
+71,193
+31% +$3.15M 0.04% 402
2016
Q1
$10.8M Buy
233,332
+8,050
+4% +$389K 0.04% 389
2015
Q4
$12.2M Buy
225,282
+5,236
+2% +$252K 0.05% 349
2015
Q3
$8.87M Sell
220,046
-13,196
-6% -$736K 0.03% 412
2015
Q2
$15.8M Buy
233,242
+5,946
+3% +$420K 0.05% 330
2015
Q1
$13.5M Sell
227,296
-111,968
-33% -$6.38M 0.05% 377
2014
Q4
$19.1M Buy
339,264
+29,129
+9% +$1.56M 0.06% 308
2014
Q3
$14.1M Sell
310,135
-35,516
-10% -$1.73M 0.05% 355
2014
Q2
$17.8M Sell
345,651
-3,279
-0.9% -$161K 0.06% 326
2014
Q1
$16.9M Buy
348,930
+139,710
+67% +$6.78M 0.06% 324
2013
Q4
$9.13M Buy
209,220
+25,341
+14% +$1.04M 0.03% 435
2013
Q3
$7M Buy
183,879
+182,330
+11,771% +$6.42M 0.03% 475
2013
Q2
$48K Buy
+1,549
New +$46.3K ﹤0.01% 696

Other funds holding VTRS

Canada Life's VTRS Position: Q1 2026 in Review

Canada Life increased its Viatris (VTRS) stake by 0.23% in Q1 2026, buying an estimated $17.1K and bringing the position to 523,383 shares worth $7.08M. The position accounts for 0.01% of the portfolio, ranked #612.

Canada Life first reported a position in VTRS in Q2 2013 and has held it in 51 quarters since. The position peaked at $37M in Q4 2020. 1,019 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • Canada Life held 523,383 shares of Viatris worth $7.08M as of Q1 2026.
  • Canada Life bought 1,220 Viatris shares in Q1 2026, an estimated $17.1K.
  • Viatris made up 0.01% of Canada Life's portfolio in Q1 2026, its #612 holding.
  • Canada Life first reported a position in Viatris in Q2 2013 and has held it in 51 quarters since.
  • Canada Life's Viatris position peaked at $37M in Q4 2020.
  • 1,019 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.